Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Human HE4/WFDC2 ELISA Kit

Click to view available options
Quantity:
5 x 96 Tests
96 Tests
Description
Human HE4/WFDC2 quantitates human HE4/WFDC2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human HE4/WFDC2.
This gene encodes a protein that is a member of the WFDC domain family. The WFDC domain, or WAP Signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor in many family members. This gene is expressed in pulmonary epithelial cells, and was also found to be expressed in some ovarian cancers. The encoded protein is a small secretory protein, which may be involved in sperm maturation.

Specifications
Specifications
Accession Number | 1600023A02Rik; dJ461P17.6; EDDM4; epididymal protein 4; epididymal secretory protein 4; Epididymal secretory protein E4; epididymis-specific, whey-acidic protein type, four-disulfide core; He4; major epididymis-specific protein E4; MGC57529; Putative protease inhibitor WAP5; RE4; WAP domain containing protein HE4-V4; WAP domain-containing protein HE4; WAP four-disulfide core domain 2; WAP four-disulfide core domain protein 2; WAP5; WFDC2 |
Assay Range | 0.25 to 25 ng/mL |
Assay Sensitivity | 0.25 ng/mL |
Conjugate | HRP |
Product Type | ELISA |
Sample Type | Plasma, Serum, Supernatant |
For Use With (Equipment) | Colorimetric Microplate Reader |
Gene ID (Entrez) | 10406 |
Gene Symbol | WFDC2 |
Interassay CV | <12% |
Show More |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction